Ocular Therapeutix Stock Forecast - Period Momentum Indicator
| OCUL Stock | USD 9.44 0.09 0.96% |
Ocular Stock Forecast is based on your current time horizon. Although Ocular Therapeutix's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Ocular Therapeutix's systematic risk associated with finding meaningful patterns of Ocular Therapeutix fundamentals over time.
Ocular |
| Previous Period Momentum Indicator | Period Momentum Indicator | Trend |
| (0.45) | (0.33) |
| Check Ocular Therapeutix Volatility | Backtest Ocular Therapeutix | Trend Details |
Ocular Therapeutix Trading Date Momentum
| On December 03 2024 Ocular Therapeutix was traded for 9.49 at the closing time. The top price for the day was 10.21 and the lowest listed price was 9.41 . The trading volume for the day was 1.7 M. The trading history from December 3, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.87% . The trading delta at closing time against the current closing price is 1.02% . |
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
| Compare Ocular Therapeutix to competition |
Other Forecasting Options for Ocular Therapeutix
For every potential investor in Ocular, whether a beginner or expert, Ocular Therapeutix's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Ocular Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Ocular. Basic forecasting techniques help filter out the noise by identifying Ocular Therapeutix's price trends.Ocular Therapeutix Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ocular Therapeutix stock to make a market-neutral strategy. Peer analysis of Ocular Therapeutix could also be used in its relative valuation, which is a method of valuing Ocular Therapeutix by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Ocular Therapeutix Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Ocular Therapeutix's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Ocular Therapeutix's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Ocular Therapeutix Market Strength Events
Market strength indicators help investors to evaluate how Ocular Therapeutix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ocular Therapeutix shares will generate the highest return on investment. By undertsting and applying Ocular Therapeutix stock market strength indicators, traders can identify Ocular Therapeutix entry and exit signals to maximize returns.
| Accumulation Distribution | 18551.63 | |||
| Daily Balance Of Power | 0.3214 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 9.37 | |||
| Day Typical Price | 9.39 | |||
| Price Action Indicator | 0.11 | |||
| Period Momentum Indicator | 0.09 |
Ocular Therapeutix Risk Indicators
The analysis of Ocular Therapeutix's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Ocular Therapeutix's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ocular stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.71 | |||
| Semi Deviation | 2.78 | |||
| Standard Deviation | 3.52 | |||
| Variance | 12.37 | |||
| Downside Variance | 8.92 | |||
| Semi Variance | 7.73 | |||
| Expected Short fall | (3.43) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Ocular Therapeutix to cross-verify your projections. For more information on how to buy Ocular Stock please use our How to buy in Ocular Stock guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocular Therapeutix. If investors know Ocular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocular Therapeutix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.29) | Revenue Per Share 0.529 | Quarterly Revenue Growth 0.083 | Return On Assets (0.22) | Return On Equity (0.73) |
The market value of Ocular Therapeutix is measured differently than its book value, which is the value of Ocular that is recorded on the company's balance sheet. Investors also form their own opinion of Ocular Therapeutix's value that differs from its market value or its book value, called intrinsic value, which is Ocular Therapeutix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocular Therapeutix's market value can be influenced by many factors that don't directly affect Ocular Therapeutix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocular Therapeutix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocular Therapeutix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocular Therapeutix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.